{"name":"Correvio International Sarl","slug":"correvio-international-sarl","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-09-23","label":"Xydalba Phase 3 readout (Catheter Bacteremia, Staphylococcus Aureus Infection)","drug":"Xydalba","drugSlug":"xydalba","type":"phase3_readout","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Xydalba","genericName":"Xydalba","slug":"xydalba","indication":"Bacterial infection of skin","status":"discontinued"}]}],"pipeline":[{"name":"Xydalba","genericName":"Xydalba","slug":"xydalba","phase":"discontinued","mechanism":"Small molecule","indications":["Bacterial infection of skin","Infection of skin AND/OR subcutaneous tissue","Staphylococcal infection of skin"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPOXBkb29GTXYybWhzUWpuYWc1V1Bobkk2RWFSRzNGaHhkSGxpVm1oNnZvX0JCbFI5djRqME9tTHNad2dLd2tFZHJ6cGFjLXh1c19TRTlFQkxzaHpRRmluT25tdkNmeGdDWUZIYXJ0MlJPc2pQYVltWHprbkpsUVk5WWJndw?oc=5","date":"2020-10-22","type":"pipeline","source":"SEC.gov","summary":"ADVANZ PHARMA Corp. Limited Closes Acquisition of Specialty Pharmaceutical Company Correvio Pharma Corp. - SEC.gov","headline":"ADVANZ PHARMA Corp. Limited Closes Acquisition of Specialty Pharmaceutical Company Correvio Pharma Corp.","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"discontinued":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}